Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2022 Sep 13;75(2):373–380. doi: 10.1002/acr.24763

Table 3.

Juvenile spondyloarthritis flare (JSpAflare) core measures and frequency of flare visits where each core met the clinically meaningful change from index visit.

Core measures Clinically meaningful (absolute) change from reference/ index visit Frequency meeting flare criteria N (%)
Development Cohort Validation Cohort
1. Caregiver/patient assessment of overall well-being ≥2 12 (75.0) 4 (80.0)
2. Physician assessment of disease activity ≥2 13 (81.3) 5 (83.3)
3. Caregiver/patient assessment of pain ≥2 14 (87.5) 3 (50.0)
4. Function: PROMIS mobility or upper extremity function or CHAQ PROMIS: ≥3 CHAQ: ≥0.125 8 (80.0) 2 (40.0)
5. Active joint count ≥1 12 (75.0) 6 (100.0)

Legend. Flare defined as clinically meaningful worsening in absolute values of ≥3 core measures from the reference visit. PROMIS = Patient Reported Outcomes Measurement Information System; CHAQ = Child Health Assessment Questionnaire.